世界の口腔内崩壊錠剤市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP06849)
◆英語タイトル:Global Orally Disintegrating Tablets Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP06849
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、口腔内崩壊錠剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。口腔内崩壊錠剤の種類別市場規模(抗精神病薬、抗てんかん薬、その他)、用途別市場規模(CNS疾患、消化器疾患、CVS疾患、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Teva、Eli Lilly and Company、Pfizer、Merck、Otsuka、Mylan、Bristol-Myers Squibb、GSK、Johnson and Johnson、AstraZeneca、Conquer
・地域別グローバル市場分析 2015年-2020年
・口腔内崩壊錠剤の北米市場(アメリカ、カナダ、メキシコ)
・口腔内崩壊錠剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・口腔内崩壊錠剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・口腔内崩壊錠剤の南米市場(ブラジル、アルゼンチン)
・口腔内崩壊錠剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:抗精神病薬、抗てんかん薬、その他
・用途別分析:CNS疾患、消化器疾患、CVS疾患、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Orally Disintegrating Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Orally Disintegrating Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Orally Disintegrating Tablets market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Orally Disintegrating Tablets market has been segmented into
Anti-Psychotics Drug
Anti-Epileptics Drug
Other

By Application, Orally Disintegrating Tablets has been segmented into:
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Orally Disintegrating Tablets market presented in the report. This section sheds light on the sales growth of different regional and country-level Orally Disintegrating Tablets markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Orally Disintegrating Tablets market.

The report offers in-depth assessment of the growth and other aspects of the Orally Disintegrating Tablets market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Orally Disintegrating Tablets Market Share Analysis
Orally Disintegrating Tablets competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Orally Disintegrating Tablets sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Orally Disintegrating Tablets sales, revenue and market share for each player covered in this report.

The major players covered in Orally Disintegrating Tablets are:
Teva
Eli Lilly and Company
Pfizer
Merck
Otsuka
Mylan
Bristol-Myers Squibb
GSK
Johnson and Johnson
AstraZeneca
Conquer

Among other players domestic and global, Orally Disintegrating Tablets market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablets, with price, sales, revenue and global market share of Orally Disintegrating Tablets in 2018 and 2019.
Chapter 3, the Orally Disintegrating Tablets competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablets breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Orally Disintegrating Tablets market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Orally Disintegrating Tablets sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Orally Disintegrating Tablets Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orally Disintegrating Tablets Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Orally Disintegrating Tablets Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Overview of Global Orally Disintegrating Tablets Market
1.4.1 Global Orally Disintegrating Tablets Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly and Company SWOT Analysis
2.2.4 Eli Lilly and Company Product and Services
2.2.5 Eli Lilly and Company Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Otsuka
2.5.1 Otsuka Details
2.5.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Otsuka SWOT Analysis
2.5.4 Otsuka Product and Services
2.5.5 Otsuka Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bristol-Myers Squibb SWOT Analysis
2.7.4 Bristol-Myers Squibb Product and Services
2.7.5 Bristol-Myers Squibb Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GSK SWOT Analysis
2.8.4 GSK Product and Services
2.8.5 GSK Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson and Johnson SWOT Analysis
2.9.4 Johnson and Johnson Product and Services
2.9.5 Johnson and Johnson Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AstraZeneca SWOT Analysis
2.10.4 AstraZeneca Product and Services
2.10.5 AstraZeneca Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Conquer
2.11.1 Conquer Details
2.11.2 Conquer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Conquer SWOT Analysis
2.11.4 Conquer Product and Services
2.11.5 Conquer Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Orally Disintegrating Tablets Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Orally Disintegrating Tablets Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Orally Disintegrating Tablets Manufacturer Market Share in 2019
3.3.2 Top 6 Orally Disintegrating Tablets Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Orally Disintegrating Tablets Sales, Revenue and Market Share by Regions
4.1.1 Global Orally Disintegrating Tablets Sales and Market Share by Regions (2015-2020)
4.1.2 Global Orally Disintegrating Tablets Revenue and Market Share by Regions (2015-2020)
4.2 North America Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
4.3 Europe Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
4.5 South America Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Orally Disintegrating Tablets Sales, Revenue and Market Share by Country
5.1.1 North America Orally Disintegrating Tablets Sales and Market Share by Country (2015-2020)
5.1.2 North America Orally Disintegrating Tablets Revenue and Market Share by Country (2015-2020)
5.2 United States Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
5.3 Canada Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
5.4 Mexico Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Orally Disintegrating Tablets Sales, Revenue and Market Share by Country
6.1.1 Europe Orally Disintegrating Tablets Sales and Market Share by Country (2015-2020)
6.1.2 Europe Orally Disintegrating Tablets Revenue and Market Share by Country (2015-2020)
6.2 Germany Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
6.3 UK Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
6.4 France Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
6.5 Russia Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
6.6 Italy Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Orally Disintegrating Tablets Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Orally Disintegrating Tablets Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Orally Disintegrating Tablets Revenue and Market Share by Regions (2015-2020)
7.2 China Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
7.3 Japan Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
7.4 Korea Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
7.5 India Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
7.7 Australia Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Orally Disintegrating Tablets Sales, Revenue and Market Share by Country
8.1.1 South America Orally Disintegrating Tablets Sales and Market Share by Country (2015-2020)
8.1.2 South America Orally Disintegrating Tablets Revenue and Market Share by Country (2015-2020)
8.2 Brazil Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
8.3 Argentina Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Orally Disintegrating Tablets Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Orally Disintegrating Tablets Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Orally Disintegrating Tablets Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
9.3 Turkey Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
9.4 Egypt Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
9.5 South Africa Orally Disintegrating Tablets Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Orally Disintegrating Tablets Sales and Market Share by Type (2015-2020)
10.2 Global Orally Disintegrating Tablets Revenue and Market Share by Type (2015-2020)
10.3 Global Orally Disintegrating Tablets Price by Type (2015-2020)
11 Global Orally Disintegrating Tablets Market Segment by Application
11.1 Global Orally Disintegrating Tablets Sales Market Share by Application (2015-2020)
11.2 Global Orally Disintegrating Tablets Revenue Market Share by Application (2015-2020)
11.3 Global Orally Disintegrating Tablets Price by Application (2015-2020)
12 Market Forecast
12.1 Global Orally Disintegrating Tablets Sales, Revenue and Growth Rate (2021-2025)
12.2 Orally Disintegrating Tablets Market Forecast by Regions (2021-2025)
12.2.1 North America Orally Disintegrating Tablets Market Forecast (2021-2025)
12.2.2 Europe Orally Disintegrating Tablets Market Forecast (2021-2025)
12.2.3 Asia-Pacific Orally Disintegrating Tablets Market Forecast (2021-2025)
12.2.4 South America Orally Disintegrating Tablets Market Forecast (2021-2025)
12.2.5 Middle East & Africa Orally Disintegrating Tablets Market Forecast (2021-2025)
12.3 Orally Disintegrating Tablets Market Forecast by Type (2021-2025)
12.3.1 Global Orally Disintegrating Tablets Sales Forecast by Type (2021-2025)
12.3.2 Global Orally Disintegrating Tablets Market Share Forecast by Type (2021-2025)
12.4 Orally Disintegrating Tablets Market Forecast by Application (2021-2025)
12.4.1 Global Orally Disintegrating Tablets Sales Forecast by Application (2021-2025)
12.4.2 Global Orally Disintegrating Tablets Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Teva、Eli Lilly and Company、Pfizer、Merck、Otsuka、Mylan、Bristol-Myers Squibb、GSK、Johnson and Johnson、AstraZeneca、Conquer

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の口腔内崩壊錠剤市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Orally Disintegrating Tablets Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。